Although αPD-1 led to a moderate (although not significant) increase in CD45+ tumor infiltration, aNK1.1 did not cause any change in the immune infiltration pattern [Fig. 3F; Supplementary Fig. S7C (right)]. The gene discussed is PTPRC; the disease is neoplasm.